Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantBOEHRINGER INGELHEIM SINGAPORE PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
TABLET, FILM COATED
ORAL
Medical Information
L01XE13
xl 01 xe 13
Manufacturer Information
BOEHRINGER INGELHEIM SINGAPORE PTE. LTD.
Boehringer Ingelheim Pharma GmbH & Co. KG
Active Ingredients
Documents
Package Inserts
Giotrif Tablet PI.pdf
Approved: March 16, 2022